Pharmacy benefit managers (PBMs), the subject of a new report published by the House Committee on Oversight and Accountability (Oversight Committee), found the entities behave anticompetitively in order to push drug costs up for patients. The report was released prior to a contentious committee hearing with the three largest PBMs.
The...
